Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
San Raffaele University
Fudan University
St. Jude Children's Research Hospital
Novartis
GlaxoSmithKline
UNICANCER
ImmunityBio, Inc.
Sun Yat-sen University
Massive Bio, Inc.
7 Hills Pharma, LLC
National Cancer Institute (NCI)
University of Pittsburgh
Medicenna Therapeutics, Inc.
AIO-Studien-gGmbH
GERCOR - Multidisciplinary Oncology Cooperative Group
Sanford Health
M.D. Anderson Cancer Center
WellSpan Health